Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotide modulation of tumor necrosis factor-(.alpha.) (TNF-.alpha.) expression

Antisense oligonucleotide modulation of tumor necrosis factor-(.alpha.) (TNF-.alpha.) expression

US Patent 6228642 · Granted May 8, 2001

Estimated economic value: $4,053,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides directed to huntingtin2025
Methods of treating conditions related to the S1P1 receptor2025
Selective reduction of allelic variants2024
Methods of treating conditions related to the S1P1 receptor2024
Compositions for modulating Ataxin 2 expression2023
Methods for treating Alzheimer's disease2023
Compositions and methods for modulation of SMN2 splicing in a subject2022
Compositions and methods for modulation of protein aggregation2022
Modulation of Huntington expression2022
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof2022
Antisense compounds and uses thereof2022
Combinations for the modulation of SMN expression2021